These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23615136)

  • 1. Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.
    Mahon SM
    Oncol Nurs Forum; 2013 May; 40(3):220-2. PubMed ID: 23615136
    [No Abstract]   [Full Text] [Related]  

  • 2. Which individuals undergoing BRACAnalysis need BART testing?
    Shannon KM; Rodgers LH; Chan-Smutko G; Patel D; Gabree M; Ryan PD
    Cancer Genet; 2011 Aug; 204(8):416-22. PubMed ID: 21962891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
    Buffone A; Capalbo C; Ricevuto E; Sidoni T; Ottini L; Falchetti M; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
    Breast Cancer Res Treat; 2007 Dec; 106(2):289-96. PubMed ID: 17333342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
    del Valle J; Feliubadaló L; Lázaro C
    Breast Cancer Res Treat; 2010 Nov; 124(1):295-6. PubMed ID: 20706784
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay.
    Manguoğlu E; Güran S; Yamaç D; Simşek M; Akdeniz S; Colak T; Gülkesen H; Lüleci G
    Cancer Invest; 2011 Jan; 29(1):73-7. PubMed ID: 20919953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic testing in patients at risk for carcinoma of the breast].
    Kiechle M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case against BRCA 1 and 2 testing.
    Lin C; Sasaki T; Strumwasser A; Harken A
    Surgery; 2011 Jun; 149(6):731-4. PubMed ID: 21621683
    [No Abstract]   [Full Text] [Related]  

  • 10. Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families.
    Gad S; Klinger M; Caux-Moncoutier V; Pages-Berhouet S; Gauthier-Villars M; Coupier I; Bensimon A; Aurias A; Stoppa-Lyonnet D
    J Med Genet; 2002 Nov; 39(11):817-21. PubMed ID: 12414821
    [No Abstract]   [Full Text] [Related]  

  • 11. Two double heterozygotes in a South African Afrikaner family: implications for BRCA1 and BRCA2 predictive testing.
    Loubser F; de Villiers JN; van der Merwe NC
    Clin Genet; 2012 Dec; 82(6):599-600. PubMed ID: 22486351
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of hereditary breast cancer.
    Quan ML; Petrek JA
    Adv Surg; 2003; 37():197-212. PubMed ID: 12953634
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
    Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
    Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
    Domchek SM; Rebbeck TR
    LDI Issue Brief; 2010; 16(2):1-4. PubMed ID: 21545057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA screening.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):93-4. PubMed ID: 18007543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic changes in breast cancer - an overview].
    Dimitrov G; Iovchev I; Nikolov S
    Khirurgiia (Sofiia); 2000; 56(5-6):60-2. PubMed ID: 11692938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
    Domchek SM; Gaudet MM; Stopfer JE; Fleischaut MH; Powers J; Kauff N; Offit K; Nathanson KL; Robson M
    Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer susceptibility genes.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(22):12-4; quiz 14. PubMed ID: 10542765
    [No Abstract]   [Full Text] [Related]  

  • 20. Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?
    Yurgelun MB; Hiller E; Garber JE
    J Clin Oncol; 2015 Oct; 33(28):3092-5. PubMed ID: 26282646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.